Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3935286
Max Phase: Preclinical
Molecular Formula: C18H14N4O3
Molecular Weight: 334.33
Molecule Type: Small molecule
Associated Items:
ID: ALA3935286
Max Phase: Preclinical
Molecular Formula: C18H14N4O3
Molecular Weight: 334.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1cn(Cc2ccccc2)nn1
Standard InChI: InChI=1S/C18H14N4O3/c23-18(11-8-14-6-9-16(10-7-14)22(24)25)17-13-21(20-19-17)12-15-4-2-1-3-5-15/h1-11,13H,12H2/b11-8+
Standard InChI Key: USXCYZXUYYLSGG-DHZHZOJOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 334.33 | Molecular Weight (Monoisotopic): 334.1066 | AlogP: 3.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 90.92 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.99 | CX LogD: 3.99 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.30 | Np Likeness Score: -1.50 |
1. (2015) Cinnamoyl inhibitors of transglutaminase, |
Source(1):